May hopes come true!
OVULOFERT is safe and effective fortreatment of infertile women with polycystic syndrome ovaries / PCOS / as well as preparation for the IVF procedure.
The advantage of OVULOFERT is the presence in the complex MYO INOZITOL.
MYO INOZITOL is a vitamin-like substance with special properties: it is a safe, effective alternative component of treatment of infertile women with polycystic ovary syndrome / PCOS /, as well as for preparing for high-tech procedures IVF / ICSI.
Source of Myo- Inositol and vitamin support:
• to prepare the female body for conception and increase the likelihood of pregnancy;
•in preparation for IVF, especially for women with PCOS (polycystic ovary syndrome);
•to prepare for the cycles of intracytoplasmic sperm injection (ICSI) in order to improve the functional status of oocytes in patients with PCOS;
•to increase the possibility of women`s ovulation and fertility (in order to improve the quality of the eggs and the rate of pregnancy);
•to increase progesterone levels;
•to reduce testosterone levels;
•as an adjunct in PCOS, for insulin resistance, prediabetes, and type II diabetes;
•to replenish vitamins in a woman’s body when planning pregnancy;
•in preparation for pregnancy of women with an increased risk of miscarriage;
• to reduce the vegetative manifestations of menopausal disorders.
Carefully selected components and the effectiveness of each of these vital substances have a positive effect on the preparation of a woman’s body for a long-awaited pregnancy.
Serving Size: Each pack contains 60 tablets 1260 mg each.
2 tablets contains:
Vitamin A- |
0.9mg |
%100* |
VitaminB 6- |
2mg |
%100* |
Inositol (Mio-Inositol 2000mg, D-Chyro-Inositol-410mg)- |
2410mg |
%150* |
Folic Acid- |
0,2mg |
%100* |
Vitamin B12- |
3mcg |
%100* |
Vitamin E- |
20 mg |
%81* |
* -% of the daily requirement (does not exceed the upper permissible level of consumption).
Usage Instructions:
2 capsules 1 time a day before meals or during meals. To clarify the dosage before taking, the doctor's consultation needed.
Menstruation day, ovulation, or other indicators do not have fundamental importance to start treatment .
It is recommended to start taking OVULOFERT for 3 -6 months before the planned pregnancy.
CONTRAINDICATIONS: Individual intolerance to the components of the complex,pregnancy, breastfeeding.
Recommended to consult with a doctor.
STORAGE CONDITIONS: Keep out of reach of children, in a dry place, at room temperature.
“Ovulofert” is a product and trademark of “BonPharm”.


CALCEPTIN


VIZIFORT H
